Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways (Q28546871)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways |
scientific article |
Statements
Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways (English)
0 references
1 reference
Yuping Liu
1 reference
Pingting Zhu
1 reference
Yingyu Wang
1 reference
Zhonghong Wei
1 reference
Li Tao
1 reference
Zhijie Zhu
1 reference
Xiaobo Sheng
1 reference
Siliang Wang
1 reference
Junshan Ruan
1 reference
Zhaoguo Liu
1 reference
Yuzhu Cao
1 reference
Yunlong Shan
1 reference
Lihua Sun
1 reference
Aiyun Wang
1 reference
Yin Lu
1 reference
2015
0 references
10
0 references
4
0 references
e0123781
0 references
30 April 2015
1 reference
1 reference
1 reference
1 reference
1 reference